Professor Dr med. Dirk Müller-Wieland has made an outstanding contribution to the German Diabetes Association (DDG). In recognition of his many years of extensive commitment, the internist specialising in diabetology and endocrinology, who works at the University Hospital Aachen, was honoured by the professional society with the Hellmut Otto Medal in June. The award is named after Professor Dr Hellmut Otto, who is regarded as a pioneer in the research and treatment of diabetes in Germany.
One topic that is particularly close to Prof. Müller-Wieland’s heart is how the care of people with diabetes mellitus and comorbidities such as chronic heart failure can be improved with the help of digitalisation. This does not only refer to digital health applications (DiGA) for mobile phones, tablets and PCs or virtual advanced training and continuing education programmes for physicians, but also and above all to the implementation of the electronic diabetes record (eDA). “In recent years, the DDG as a professional society has already been able to establish acceptance for the eDA. Now the main question is how the electronic diabetes record can be implemented as a complement to the electronic patient record,” explains the internist.
A project close to the heart: the electronic diabetes record
The aim of the eDA, together with the associated diabetes register, is to bring together people with diabetes mellitus, treatment teams and research institutions through an efficient data pool. By analysing data patterns, new correlations, subgroups, clinical courses and therapeutic approaches are to be identified. Predictive models could also make it possible to identify individuals at risk at an early stage and with precision.
Well-designed digital infrastructure, high-quality care
“This enables us to treat patients according to the latest DDG standards and to continuously optimise therapies,” explains Prof. Müller-Wieland. In his view, a well-designed digital infrastructure could also help ensure comprehensive specialisation and interdisciplinary care. “That would be a decisive step towards making internal medicine fit for the future,” he emphasises. It is equally important to the internist to ensure that findings from diabetological research reach patients as early as possible. He sees this both as an ongoing challenge and as a responsibility for his field.
From his perspective, digitalisation and translation do not exclude one another but, working together and even across sector boundaries, provide important insights. Basic research addresses key questions in the life sciences, while new clinical developments generate interdisciplinary impulses, including the integration of digital innovations, for fields such as cardiology, nephrology, hepatology and neurology. His own clinical and scientific focus is on disorders of lipid metabolism in diabetes mellitus and metabolically induced cardiovascular complications.
“Whether in research, hospitals or medical practices – only together can we optimise the care of people with diabetes and lead our discipline confidently into the future with a strong DDG,” the diabetologist explains.
Active for the DDG for many years and with great dedication
From 2017 to 2019, Prof. Müller-Wieland served as President of the German Diabetes Association; since 2019 he has been spokesperson of the Digitalisation Commission. He originally founded the commission himself and remains active there, advocating “with determination” for “responsible digitalisation in diabetology”, as laudator Professor Dr Monika Kellerer emphasised during the award ceremony at the Diabetes Congress. In the Committee for Quality Assurance, Training & Continuing Education, Prof. Müller-Wieland also continues to serve as spokesperson – and has helped initiate several training and continuing education programmes as well as advancing important projects such as the module certificates.
In addition, Prof. Müller-Wieland was President of the Diabetes Congress in 2017; he had already assumed this role in 2016 following the death of Professor Dr Stephan Matthaei. Within the German Society of Internal Medicine, Prof. Müller-Wieland is Co-Chair of the commission “Structure of Hospital Care”.
From Hamburg via Boston to Cologne, Düsseldorf, back to Hamburg – and finally to Aachen
Professor Dr Dirk Müller-Wieland studied human medicine in Hamburg. This was followed by a two-year research stay at Harvard Medical School in Boston, USA. He completed his specialist training as an internist with a focus on endocrinology, diabetology and metabolism at the University Medical Centre Hamburg-Eppendorf and at the University of Cologne.
In 1997 he was appointed to a university professorship for Internal Medicine/Endocrinology in Cologne. Four years later, Prof. Müller-Wieland moved to the Chair of Clinical Biochemistry at Heinrich Heine University Düsseldorf and became Director at the German Diabetes Center.
From 2006 to 2015 he worked as Chief Physician at Asklepios Klinik St. Georg in Hamburg and, among other roles, helped shape what was then the first trans-European degree programme as Dean of the Asklepios Campus Hamburg of the Medical Faculty of Semmelweis University in Budapest, Hungary.
In 2016 he moved to the University Hospital of RWTH Aachen with a focus on cardiometabolic prevention. There he heads the Clinical Study Centre of the Clinic for Cardiology, Angiology and Internal Intensive Care Medicine (Medical Clinic I).
Source: Medical-Tribune report